CDC/ACIP [U.S.] [to 11 Sep 2021]
http://www.cdc.gov/media/index.html
https://www.cdc.gov/vaccines/acip/index.html
Latest News Releases, Announcements
AmeriCorps and CDC Launch Public Health AmeriCorps, Seek Proposals to Build a New Generation of Public Health Leaders
Wednesday, September 8, 2021

Next ACIP Meeting – September 29, 2021, 10:00 a.m. – 5:30 p.m. virtual meeting.
No registration is required to watch the webcast.
No agenda posted as 11 Sep 2021
Webcast Linkexternal icon

MMWR News Synopsis Friday, September 10, 2021
:: Long-Term Symptoms Among Adults Tested for SARS-CoV-2 — United States, January 2020–April 2021
:: Using Wastewater Surveillance Data to Support the COVID-19 Response — United States, 2020–2021
:: SARS-CoV-2 Transmission to Masked and Unmasked Close Contacts of University Students with COVID-19 — St. Louis, Missouri, January–May 2021
:: Trends in COVID-19 Cases, Emergency Department Visits, and Hospital Admissions Among Children and Adolescents Aged 0–17 Years — United States, August 2020–August 2021
:: Hospitalizations Associated with COVID-19 Among Children and Adolescents — COVID-NET, 14 States, March 1, 2020–August 14, 2021

Coronavirus Disease 2019 (COVID-19)– CDC
Approximately 25 announcements/reports/data summaries.
:: Overall US COVID-19 Vaccine Distribution and Administration Update as of Sat, 11 Sep 2021 06:00:00 EST

Africa CDC [to 11 Sep 2021]
http://www.africacdc.org/
News
Press Releases
African Vaccine Acquisition Trust delivers 108,000 doses of COVID-19 vaccine to Ethiopia
6 September 2021

China CDC http://www.chinacdc.cn/en/

National Health Commission of the People’s Republic of China [to 11 Sep 2021]
http://en.nhc.gov.cn/
News
Sept 11: Daily briefing on novel coronavirus cases in China
On Sept 10, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 25 new cases of confirmed infections

National Medical Products Administration – PRC [to 11 Sep 2021]
http://english.nmpa.gov.cn/news.html
News
Seminar held to boost drug regulatory cooperation between BRI countries
2021-09-11
Co-sponsored by China’s National Medical Products Administration (NMPA) and Ministry of Commerce, the Seminar on Drug Regulation and Development Cooperation for Belt and Road Countries and the Opening Session of the Seminar on Regulation Cooperation and Industry Development of Medical Products for Belt and Road Countries were held in Beijing both online and offline on Sept 1.

Xi: China to donate another 100m doses of COVID vaccines
2021-09-10
China will donate 100 million more doses of COVID-19 vaccines to developing countries within this year on top of a donation of $100 million to COVAX, President Xi Jinping said on Sept 9.

Nearly 2.12b doses of COVID-19 vaccines administered in China
2021-09-09
Nearly 2.12 billion doses of COVID-19 vaccines had been administered in China as of Tuesday, data from the National Health Commission showed on Sept 8.

CCDC Weekly – Weekly Reports: Current Volume (3)
2021-09-10 / No. 37
PDF of this issue
No new digest content identified.

::::::

Organization Announcements
Editor’s Note:
Careful readers will note that the number and range of organizations now monitored in our Announcements section below has grown as the impacts of the pandemic have spread across global economies, supply chains and programmatic activity of multilateral agencies and INGOs.
 
 
Paul G. Allen Frontiers Group [to 11 Sep 2021]
https://alleninstitute.org/what-we-do/frontiers-group/news-press/
News
Sped-up evolution may have molded the human brain by slowing neuron growth
September 9, 2021
Quickly evolving stretches of DNA unique to humans are important for brain development, a new study finds
 
 
BARDA – U.S. Department of HHS [to 11 Sep 2021]
https://www.phe.gov/about/barda/Pages/default.aspx
News
No new digest content identified.
 
 
BMGF – Gates Foundation [to 11 Sep 2021]
https://www.gatesfoundation.org/ideas/media-center
Press Releases and Statements
No new digest content identified.
 
 
Bill & Melinda Gates Medical Research Institute [to 11 Sep 2021]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.
 
 
CARB-X [to 11 Sep 2021]
https://carb-x.org/
News
No new digest content identified.
 
 
Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 11 Sep 2021]
https://centerforvaccineethicsandpolicy.net/
News/Analysis/Statements
:: Past weekly editions and posting of all segments of Vaccines and Global Health: The Week in Review are available here.
:: [NEW] Informed Consent: A Monthly Review – September 2021 is now posted here
 
 
CEPI – Coalition for Epidemic Preparedness Innovations [to 11 Sep 2021]
http://cepi.net/
Latest News
Joint COVAX statement on Supply Forecast for 2021 and early 2022
According to its latest Supply Forecast, COVAX expects to have access to 1.425 billion doses of vaccine in 2021.
08 Sep 2021
[See Milestones above for detail]

Comparator vaccines are needed if vital COVID-19 R&D is to progress
Governments, developers, and particularly vaccine manufacturers, must urgently agree upon a solution to unlock supplies, writes CEPI’s Director of Vaccine R&D, Melanie Saville.
07 Sep 2021
[See Milestones above for detail]
 
 
DARPA – Defense Advanced Research Projects Agency [to 11 Sep 2021
https://www.darpa.mil/news
News
No new digest content identified.
 
 
Duke Global Health Innovation Center [to 11 Sep 2021]
https://dukeghic.org/
Our Blog
A Call for a Global Summit to End the COVID-19 Pandemic
SEPTEMBER 1, 2021
Endorsed by a broad coalition of leaders and organizations.
[See Milestones above for detail]
 
 
EDCTP [to 11 Sep 2021]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
No new digest content identified.
 
 
Emory Vaccine Center [to 11 Sep 2021]
http://www.vaccines.emory.edu/
Vaccine Center News
No new digest content identified.
 
 
European Vaccine Initiative [to 11 Sep 2021]
http://www.euvaccine.eu/
Latest News
No new digest content identified.
 
 
Fondation Merieux [to 11 Sep 2021]
http://www.fondation-merieux.org/
News, Events
No new digest content identified.
 
 
Gavi [to 11 Sep 2021]
https://www.gavi.org/
8 September 2021
First delivery of German-donated COVID vaccines to COVAX land in Mauritania, with other deliveries to follow

8 September 2021
Joint COVAX statement on Supply Forecast for 2021 and early 2022
[See Milestones above for deatil]

7 September 2021
Gavi funding boosts yellow fever diagnostics capacity across Africa

6 September 2021
First doses donated by Belgium through COVAX arrive to Armenia

GHIT Fund [to 11 Sep 2021]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 212 with the aim of developing new tools to tackle infectious diseases that
No new digest content identified.
 
 
Global Fund [to 11 Sep 2021]
https://www.theglobalfund.org/en/news/
News & Stories
News
Global Fund Results Report Reveals COVID-19 Devastating Impact on HIV, TB and Malaria Programs
08 September 2021
The COVID-19 pandemic had a devastating impact on the fight against HIV, TB and malaria in 2020, according to a new report released by the Global Fund today. The Results Report shows that while some progress was made, key programmatic results have declined for the first time in the history of the Global Fund.
 
 
Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 11 Sep 2021]
https://www.glopid-r.org/news/
GloPID-R Scientific Advisory Group releases report with COVID-19 research priorities and recommendations
06/09/2021
[See Milestones above for detail]
 
 
Hilleman Laboratories [to 11 Sep 2021]
http://www.hillemanlabs.org/
Website reports “under maintenance” at inquiry
 
 
Human Vaccines Project [to 11 Sep 2021]
http://www.humanvaccinesproject.org/
News
No new digest content identified.
 
 
IAVI [to 11 Sep 2021]
https://www.iavi.org/newsroom
Latest News
No new digest content identified.

International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.
 
 
ICRC [to 11 Sep 2021]
https://www.icrc.org/en/whats-new
Selected News Releases, Statements, Reports
No new digest content identified.

IFFIm
http://www.iffim.org/
Press Releases/Announcements
No new digest content identified.
 
 
IFRC [to 11 Sep 2021]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
No new digest content identified.
 
 
Institut Pasteur [to 11 Sep 2021]
https://www.pasteur.fr/en/press-area
Press Documents
No new digest content identified.
 
 
IOM / International Organization for Migration [to 11 Sep 2021]
http://www.iom.int/press-room/press-releases
News
No new digest content identified.
 
 
ISC / International Science Council [to 11 Sep 2021]
https://council.science/current/
ISC is a non-governmental organization with a unique global membership that brings together 40 international scientific Unions and Associations and over 140 national and regional scientific organizations including Academies and Research Councils.
News
No new digest content identified.
 
 
IVAC [to 11 Sep 2021]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates; Events
No new digest content identified.
 
 
IVI [to 11 Sep 2021]
http://www.ivi.int/
Selected IVI News, Announcements, Events
IVI’s 20th International Vaccinology Course brings virtual training to vaccine professionals and students across 155 countries
 
 
Johns Hopkins Center for Health Security [to 11 Sep 2021]
https://www.centerforhealthsecurity.org/news/center-news/
Center News
No new digest content identified.
 
 
MSF/Médecins Sans Frontières [to 11 Sep 2021]
http://www.msf.org/
Latest [Selected Announcements]
 
 
Ethiopia
Amid enormous needs in Ethiopia, MSF forced to suspend majority of healthcare
Statement 10 Sep 2021

Afghanistan
Afghanistan: Medical needs grow as international organisations suspend activities
Voices from the Field 6 Sep 2021
 
 
National Academy of Medicine – USA [to 11 Sep 2021]
https://nam.edu/programs/
Selected News/Programs
No new digest content identified.
 
 
National Academy of Sciences – USA [to 11 Sep 2021]
http://www.nasonline.org/news-and-multimedia/
News
No new digest content identified.
 
 
National Vaccine Program Office – U.S. HHS [to 11 Sep 2021]
https://www.hhs.gov/vaccines/about/index.html
Upcoming Meetings/Latest Updates
Upcoming Meetings
September 14-15, 2021 NVAC Meeting
 
 
NIH [to 11 Sep 2021]
http://www.nih.gov/news-events/news-releases
News Releases
NIH providing $185 million for research to advance understanding of how human genome functions
Thursday, September 9, 2021
The newly launched Impact of Genomic Variation on Function (IGVF) consortium to include 30 U.S. sites.
 
 
PATH [to 11 Sep 2021]
https://www.path.org/media-center/
Press Releases
PATH welcomes Nabeel Goheer as Chief of Asia, Middle East, Europe (AMEE) Region
September 10, 2021
Dr. Nabeel Goheer is joining PATH to serve as the Chief of Asia, Middle East, Europe (AMEE) Region. In this role, he will provide strategic leadership and guidance, overseeing program activities in the regional hubs in South Asia, South East Asia, Eastern Europe, Central Asia, China, and Western Europe, as well as PATH’s other projects in the region. He will also develop and execute on strategies to expand and grow the AMEE portfolio into new regions, including the Middle East and additional countries in Asia…
 
 
Sabin Vaccine Institute [to 11 Sep 2021]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
No new digest content identified.
 
 
UNAIDS [to 11 Sep 2021]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
8 September 2021
Central African Republic adopts plan to address gender inequality in the AIDS response

6 September 2021
Global roll-out of HIV treatment has saved millions of lives

6 September 2021
Anambra, Nigeria, commits to eliminating vertical transmission of HIV by end of 2022
 
 
UNHCR Office of the United Nations High Commissioner for Refugees [to 11 Sep 2021]
http://www.unhcr.org/en-us/media-centre.htmlS
Selected News Releases, Announcements
No new digest content identified.

UNICEF [to 11 Sep 2021]
https://www.unicef.org/media/press-releases
Press Releases, News Notes, Statements [Selected]
Press release
09/08/2021
Repeated school closures due to COVID-19 leading to learning loss and widening inequities in South Asia, UNICEF research shows
Limited access to devices, low connectivity, and limited teacher contact are severely constraining remote learning in the region

Statement
09/08/2021
Joint COVAX statement on supply forecast for 2021 and early 2022
[See Milestones above for detail]

Remarks
09/07/2021
UNICEF Executive Director Henrietta Fore’s Remarks at the UNICEF Executive Board
As prepared for delivery

Unitaid [to 11 Sep 2021]
https://unitaid.org/
Featured News
No new digest content identified.
 
 
Vaccine Equity Cooperative [nee Initiative] [to 11 Sep 2021]
https://vaccineequitycooperative.org/news/
News
No new digest content identified.
 
 
Vaccination Acceptance & Demand Initiative [Sabin) [to 11 Sep 2021]
https://www.vaccineacceptance.org/
Announcements
No new digest content identified.
 
 
Vaccine Confidence Project [to 11 Sep 2021]
http://www.vaccineconfidence.org/
News, Research and Reports
Coronavirus global impact
Launched April 2, 2020 and recurring every 3 days, Premise Data is utilizing its global network of Contributors to assess economic, social, and health sentiment surrounding the coronavirus (COVID-19).
 
 
Vaccine Education Center – Children’s Hospital of Philadelphia [to 11 Sep 2021]
http://www.chop.edu/centers-programs/vaccine-education-center
News
No new digest content identified.
 
 
Wellcome Trust [to 11 Sep 2021]
https://wellcome.ac.uk/news
News and reports
Photo story
The next pandemic: Why deforestation in DRC could release new viruses
6 September 2021
Authors: Amelia Goldsmith, Hugh Kinsella Cunningham
Covid-19 alerted the world to the devastating potential of pandemics in the 21st century. Photojournalist Hugh Kinsella Cunningham and writer and public health professional, Amelia Goldsmith, document how the lasting effects of colonisation, including the unbridled exploitation of natural resources, in the Democratic Republic of the Congo, could expose humanity to the next supervirus.
 
 
The Wistar Institute [to 11 Sep 2021]
https://www.wistar.org/news/press-releases
Press Releases
No new digest content identified.
 
 
WFPHA: World Federation of Public Health Associations [to 11 Sep 2021]
https://www.wfpha.org/
Latest News
No new digest content identified.
 
 
World Bank [to 11 Sep 2021]
http://www.worldbank.org/en/news/all
Selected News, Announcements
The World Bank, UNICEF Support COVID-19 Vaccine Deployment and Lifesaving Health Services for Children and Women in South Sudan
JUBA, September 09, 2021 – The World Bank and UNICEF are collaborating to implement a $53.5 million project in South Sudan that focuses on COVID-19 (Coronavirus) vaccine deployment in the country and the provision of essential health services for the most vulnerable populations in two of the most hard-to-reach areas – the states of Jonglei and Upper Nile.

This close collaboration between the World Bank and UNICEF in South Sudan comes at a crucial time as the country continues to respond to the COVID-19 pandemic including the scaling up of its vaccination roll out efforts. Both sides will also support the Ministry of Health in enhancing its stewardship of the South Sudanese health system and its capacity to plan and implement programs.

“The World Bank values its partnership with UNICEF as it focuses on the urgent task of COVID19 vaccine deployment and the supply of life-saving interventions to the most vulnerable children and women in South Sudan. It also seeks to build capacity of the Ministry of Health at the national, state and community levels to ensure sustainable access to basic health services for all resident of the country,” said Firas Raad, World Bank Country Manager for South Sudan.

Through this collaboration, initiated in 2018, UNICEF has been implementing a World Bank-financed health sector project that provides essential maternal and child health services in Jonglei and Upper Nile. The project has so far immunized 126,489 children with the penta3 vaccine and 127,912 children with the measles vaccines and provided 55,404 pregnant women with antenatal care services. It also ensured that 20,651 new-borns were delivered with the help of skilled health personnel. The project also facilitated the delivery of 587 tons of medical supplies and medicines; and supplied soap, buckets, and water purification tablets for 685,000 people in both states…

COVID-19 vaccines: from rejection to shortage, how Côte d’Ivoire became a model for managing vaccine hesitancy
ABIDJAN, Sept 7, 2021— One month after Côte d’Ivoire’s vaccination campaign was launched with much fanfare, the great enthusiasm generated by the delivery of 504,000 doses of the AstraZeneca vaccine on…
Date: September 07, 2021 Type: Feature Story
 
 
World Customs Organization – WCO [to 11 Sep 2021]
http://www.wcoomd.org/
Latest News – Selected Items
No new digest content identified.
 
 
World Organisation for Animal Health (OIE) [to 11 Sep 2021]
https://www.oie.int/en/for-the-media/press-releases/2021/
Press Releases, Statements
No new digest content identified.
 
 
WTO – World Trade Organisation [to 11 Sep 2021]
http://www.wto.org/english/news_e/news_e.htm
WTO News and Events
No new digest content identified.

::::::

ARM [Alliance for Regenerative Medicine] [to 11 Sep 2021]
Press Releases – Alliance for Regenerative Medicine (alliancerm.org)
Selected Press Releases
No new digest content identified.
 
 
BIO [to 11 Sep 2021]
https://www.bio.org/press-releases
Press Releases, Letters, Testimony, Comments [Selected]
No new digest content identified.
 
 
DCVMN – Developing Country Vaccine Manufacturers Network [to 11 Sep 2021]
http://www.dcvmn.org/
News; Upcoming events
No new digest content identified.
 
 
ICBA – International Council of Biotechnology Associations [to 11 Sep 2021]
https://internationalbiotech.org/news/
News
No new digest content identified.
 
 
IFPMA [to 11 Sep 2021]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
Momentum of COVID-19 vaccine manufacturing scale up sufficient for step change in distribution
07 September 2021
[See Milestones above for detail]

R&D-based pharmaceutical industry’s innovative partnerships to meet urgent global supply needs
06 September 2021 :: 3 pages
… According to Airfinity data, as of September 2021 at least 323 manufacturing and production agreements for COVID-19 vaccines – of which 230 agreements involving technology transfer- around the globe were made public…

International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
News
No new digest content identified.
 
 
International Alliance of Patients’ Organizations – IAPO [to 11 Sep 2021]
https://www.iapo.org.uk/news/topic/6
Press and media [Selected]
No new digest content identified.
 
 
PhRMA [to 11 Sep 2021]
http://www.phrma.org/
Latest News [Selected]
A year and a half later: The biopharmaceutical industry remains committed to beating COVID-19
September 8, 2021
As an industry committed to science, our work is not over.
…Globally, vaccine manufacturers are also estimated to produce more than 11 billion doses of COVID-19 vaccines by the end of 2021 and have already delivered more than 5 billion doses around the globe…
Blog Post

Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org

AMA Journal of Ethics
Volume 23, Number 9: E667-756 Sep 2021
https://journalofethics.ama-assn.org/issue/implantable-material-and-device-regulation

Implantable Material and Device Regulation
About 10% of Americans will have a device implanted into their bodies during their lifetimes. Fewer than 0.5% of these devices, however, are likely to have been tested in rigorous clinical trials generally regarded as standard by US regulators. Despite looser regulation of materials and devices than for pharmaceuticals, clinician-investigators and the Food and Drug Administration are obligated to balance patient-subjects’ safety with demand for patients’ timely access to technologies and interventions that might improve or extend their lives. This issue investigates that tension.
From the Editor
Sep 2021
How Differently Should the FDA Regulate Drugs and Devices?
Ariel Wampler, MD
This issue invites clinicians, researchers, device representatives, and patient-safety champions to consider how to exercise sufficient caution without stifling innovation.

AMA Journal of Ethics
Volume 23, Number 9: E667-756 Sep 2021
https://journalofethics.ama-assn.org/issue/implantable-material-and-device-regulation

AMA Code of Medical Ethics’ Opinions Related to Implantable Devices
Robert Dinallo
The AMA Code of Medical Ethics offers guidance for balancing need for safety with demand for innovation.

American Journal of Public Health
August 2021 111(53)
http://ajph.aphapublications.org/toc/ajph/current

EDITORIALS
Mischievous Immunity: How Intellectual History Can Be Relevant for Current Public Health Practice
Infections, Prevention, Immunization/Vaccines, History, Epidemiology
David S. Jones

American Journal of Public Health
August 2021 111(53)
http://ajph.aphapublications.org/toc/ajph/current

EDITORIALS
Bridging Research and Practice to Implement Strategic Public Health Science
Other Statistics/Evaluation/Research, Statistics/Evaluation/Research, Public Health Practice, Community Health, Health Policy
Ross C. Brownson

American Journal of Public Health
August 2021 111(53)
http://ajph.aphapublications.org/toc/ajph/current

PERSPECTIVES
Strategies for Successful Vaccination Among Two Medically Underserved Populations: Lessons Learned From Hepatitis A Outbreaks
Substance Use, Infections, Health Service Delivery, Hepatitis, Immunization/Vaccines, Public Health Practice, Community Health, Drugs, Access to Care
Martha P. Montgomery, Maribeth Eckert, Megan G. Hofmeister, Monique A. Foster, Mark K. Weng, Ryan Augustine, Neil Gupta and Laura A. Cooley

American Journal of Public Health
August 2021 111(53)
http://ajph.aphapublications.org/toc/ajph/current

PERSPECTIVES
Examining Facebook Community Reaction to a COVID-19 Vaccine Trial on the Navajo Nation
Alec J. Calac, Cortni Bardier, Mingxiang Cai and Tim K. Mackey

American Journal of Public Health
August 2021 111(53)
http://ajph.aphapublications.org/toc/ajph/current

PERSPECTIVES
Tribal Sovereignty in Research and Community Engagement for a COVID-19 Vaccine Clinical Trial on the Navajo Nation: Beyond a Facebook Town Hall
Other Statistics/Evaluation/Research, Immunization/Vaccines, Native Americans, Statistics/Evaluation/Research, Community Health, Race/Ethnicity, Media
Laura L. Hammitt, Deionna E. Vigil and Raymond Reid

American Journal of Public Health
August 2021 111(53)
http://ajph.aphapublications.org/toc/ajph/current

POLICY
Toward a New Strategic Public Health Science for Policy, Practice, Impact, and Health Equity
Other Statistics/Evaluation/Research, Prevention, Environment, Statistics/Evaluation/Research
Rebecca Bunnell, Juliet Ryan, Charlotte Kent and the CDC Office of Science and CDC Excellence in Science Committee

BMC Health Services Research
http://www.biomedcentral.com/bmchealthservres/content
(Accessed 11 Sep 2021)

An evaluation of an influenza vaccination campaign targeting pregnant women in 27 clinics in two provinces of South Africa, 2015 – 2018
Despite prioritization, routine antenatal influenza vaccine coverage is < 16% in South Africa. We aimed to describe maternal influenza vaccine coverage in 27 antenatal clinics (ANCs) in Gauteng and Western Cap…
Authors: Kate Bishop, Meredith McMorrow, Susan Meiring, Sibongile Walaza, Liza Rossi, Sarona Mhlanga, Stefano Tempia, Azwifarwi Mathunjwa, Jackie Kleynhans, Grace D. Appiah, Johanna M. McAnerney, Heather J. Zar and Cheryl Cohen

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 11 Sep 2021)

The impact of childhood RSV infection on children’s and parents’ quality of life: a prospective multicenter study in Spain
 Several immunisation candidates against RSV are in late-stage clinical trials. To evaluate the benefits of a potential vaccination programme, both economic and health benefits will be needed. Health benefits …
Authors: Eva Díez-Gandía, Carla Gómez-Álvarez, Mónica López-Lacort, Cintia Muñoz-Quiles, Isabel Úbeda-Sansano, Javier Díez-Domingo and Alejandro Orrico-Sánchez
Citation: BMC Infectious Diseases 2021 21:924
Content type: Research
Published on: 6 September 2021

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 11 Sep 2021)

HPV vaccination uptake and administration from 2006 to 2016 in a commercially insured population of the United States
Human papillomavirus (HPV) infection can cause various cancers and can be prevented through vaccination. The American Cancer Society (ACS) has set an HPV vaccination completion target in 13-year-old children t…
Authors: Vimalanand S. Prabhu, Neha Bansal, Zhiwen Liu, Rodney Finalle, Martin Sénécal, Smita Kothari, Kemar Trowers and Evan Myers
Citation: BMC Public Health 2021 21:1629
Content type: Research article
Published on: 6 September 2021

Development in Practice
Volume 31, Issue 6, 2021
http://www.tandfonline.com/toc/cdip20/current

Article
Improved mother’s health helps in universalisation of child immunisation – myth or reality? Evidence from Assam
Shrabanti Maity, Ummey Rummana Barlaskar & Anil Bhumali
Pages: 764-780
Published online: 05 May 2021

The European Journal of Public Health
SUPPLEMENT – Volume 31, Issue Supplement_1, July 2021
https://academic.oup.com/eurpub/issue/31/Supplement_1

Supplement: E-Mental-Health: Exploring the Evidence Base and Stakeholders’ Perspectives on Internet-Based Interventions for the Prevention of Mental Health Conditions
Mental illness represents an enormous personal, social and societal burden for European citizens1 calling for the need to expand existing models of mental healthcare delivery. In Europe, the Internet is a key source of health information,2 and technology-enhanced (psychological) interventions such as Internet- and mobile-delivered applications (‘eHealth’3 and ‘m-Health’4) have become increasingly popular and studied. There is already strong evidence of the efficacy of online interventions for the prevention and treatment of several psychological disorders5,6 and meta-analyses show effect sizes similar to face-to-face interventions.7

Globalization and Health
http://www.globalizationandhealth.com/
[Accessed 11 Sep 2021]

A chair at the table: a scoping review of the participation of refugees in community-based participatory research in healthcare
Refugees often face psychosocial complexity and multi-dimensional healthcare needs. Community-Based Participatory Research (CBPR) methods have been previously employed in designing health programs for refugee communities and in building strong research partnerships in refugee communities. However, the extent to which these communities are involved remains unknown.
Authors: Tali Filler, Pardeep Kaur Benipal, Nazi Torabi and Ripudaman Singh Minhas
Citation: Globalization and Health 2021 17:103
Content type: Research
Published on: 6 September 2021

Humanitarian Exchange Magazine
Number 79, May 2021
https://odihpn.org/magazine/localisation-and-local-humanitarian-action/

Localisation and local humanitarian action
by HPN October 2020
The theme of this edition of Humanitarian Exchange is localisation+ and local humanitarian action. Five years ago this week, donors, United Nations (UN) agencies,  non-governmental organisations (NGOs), the International Committee of the Red Cross (ICRC) and International Federation of Red Cross and Red Crescent Societies (IFRC) committed within the Grand Bargain to increase multi-year investments in the institutional capacities of local and national responders, and to provide at least 25% of humanitarian funding to them as directly as possible. Since then, there is increasing consensus at policy and normative level, underscored by the Covid-19 pandemic, that local leadership should be supported.  Localisation has gone from a fringe conversation among policy-makers and aid agencies in 2016 to a formal priority under the Grand Bargain. Wider global movements on anti-racism and decolonisation have also brought new momentum to critical reflections on where power, knowledge and capacity reside in the humanitarian system. Yet progress has been slow and major gaps remain between the rhetoric around humanitarian partnerships, funding and coordination and practices on the ground.

JAMA
September 7, 2021, Vol 326, No. 9, Pages 793-880
https://jamanetwork.com/journals/jama/currentissue

Research Letter
Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples
Timothy A. Bates, BSc; Hans C. Leier, BA; Zoe L. Lyski, MS; et al.
free access has active quiz
JAMA. 2021;326(9):868-869. doi:10.1001/jama.2021.11656
This study examines the relationship between age and neutralizing antibody titers against the SARS-CoV-2 USA-WA1/2020 strain and the P.1 variant after 2 doses of the BNT162b2 vaccine.

JAMA
September 7, 2021, Vol 326, No. 9, Pages 793-880
https://jamanetwork.com/journals/jama/currentissue

Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents
Thomas Radtke, PhD; Agne Ulyte, MD, PhD; Milo A. Puhan, MD, PhD; et al.
free access has active quiz
JAMA. 2021;326(9):869-871. doi:10.1001/jama.2021.11880
This cohort study reports the prevalence of long-term symptoms in children and adolescents who had recovered from acute SARS-CoV-2 infection.

JAMA Network
COVID-19 Update September 11, 2021

These articles on COVID-19 were published across the JAMA Network in the last week.

Journal of Health Care for the Poor and Underserved (JHCPU)
Volume 32, Number 2, May 2021 Supplement
https://muse.jhu.edu/issue/44396

Table of Contents
Overview of the Issue
Kevin B. Johnson, Tiffani J. Bright, Cheryl R. Clark
…The importance of techquity—defined as the strategic development and deployment of technology in health care and health to advance health equity—was even more apparent after the events of 2020. COVID-19 upended access to care and illuminated the impact of structural racism as a cause for a widening gap of access during the pandemic. Black Lives Matter became more than a trending hashtag on Twitter, or a movement resulting in peaceful protests and calls for policy reform: it put additional focus on the issue of race as a social and not a biological construct and called into question the rationale for common practices in health care that were triggered by race. A notable example was the emerging realization that kidney function assessment was tied to race and hardwired into many of our electronic health records. The real-world evidence around our lack of techquity was incontrovertible.
This Supplemental Issue of JHCPU provides articles that describe challenges to techquity, frameworks to improve the role of technology in care, and examples of how technology can transform health, public health, and health care…

Journal of Virology
Volume 95 Number 19 September 2021
http://jvi.asm.org/content/current

Articles of Significant Interest in This Issue
Human papillomavirus (HPV) genomes replicate as extrachromosomal minichromosomes in persistently infected cells. Coursey at al. (e00686-21) defined elements in the HPV18 enhancer element that promote stable replication of viral DNA in dividing keratinocytes. They concluded that multiple elements within the enhancer contribute to stable replication and proposed that cellular pioneer factors create a favorable chromatin environment that supports and enhances the maintenance of the extrachromosomal minichromosomes.

The Lancet
Sep 11, 2021 Volume 398 Number 10304 p931-1020, e14
https://www.thelancet.com/journals/lancet/issue/current

Comment
Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine
Elizabeth T Rogawski McQuade,
Alexander Breskin

The Lancet
Sep 11, 2021 Volume 398 Number 10304 p931-1020, e14
https://www.thelancet.com/journals/lancet/issue/current

Articles
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
Amy Flaxman, et al. and the Oxford COVID Vaccine Trial group
Open Access

The Lancet
Sep 11, 2021 Volume 398 Number 10304 p931-1020, e14
https://www.thelancet.com/journals/lancet/issue/current

Viewpoint
What are the obligations of pharmaceutical companies in a global health emergency?
Ezekiel J Emanuel, et al.
Introduction
During a global health emergency, everyone is morally required to help to combat the disease. With approximately 8000–10 000 people dying every day from COVID-19, as of writing, only rapid and globally distributed vaccinations will end the pandemic. With the support of national governments, pharmaceutical companies have produced more than 250 vaccine candidates to date.
WHO, the Coalition for Epidemic Preparedness Innovations, and Gavi, the Vaccine Alliance have established COVID-19 Vaccines Global Access (COVAX) to procure and fairly distribute vaccines.¹
But much vaccine development, production, procurement, and distribution is ad hoc, generating controversy and inconsistency. Pharmaceutical companies have been criticised for knowledge hoarding, secret pricing, unreasonable profits, unfair bilateral deals, and extortionate demands for indemnification against liability.², ³ COVAX has been criticised for an absence of transparency and accountability and for ignoring need in COVID-19 vaccine distribution.⁴, ⁵, ⁶, ⁷ All parties involved in researching, developing, manufacturing, and distributing COVID-19 vaccines need guidance on their ethical obligations. We focus on pharmaceutical companies’ obligations because their capacities to research, develop, manufacture, and distribute vaccines make them uniquely placed for stemming the pandemic…

Nature
Volume 597 Issue 7875, 9 September 2021
https://www.nature.com/nature/volumes/597/issues/7875

Perspective | 08 September 2021
A roadmap for the Human Developmental Cell Atlas
This Perspective outlines the Human Developmental Cell Atlas initiative, which uses state-of-the-art technologies to map and model hum-an development across gestation, and discusses the early milestones that have been achieved.
Muzlifah Haniffa, Deanne Taylor, Matthias Zilbauer

New England Journal of Medicine
September 9, 2021 Vol. 385 No. 11
http://www.nejm.org/toc/nejm/medical-journal

Perspective
SARS-CoV-2 Human Challenge Studies — Establishing the Model during an Evolving Pandemic G. Rapeport and Others

New England Journal of Medicine
September 9, 2021 Vol. 385 No. 11
http://www.nejm.org/toc/nejm/medical-journal

“Vaccine Passport” Certification — Policy and Ethical Considerations M.A. Hall and D.M. Studdert

New England Journal of Medicine
September 9, 2021 Vol. 385 No. 11
http://www.nejm.org/toc/nejm/medical-journal

Original Articles
Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention D. Chandramohan and Others

PharmacoEconomics
Volume 39, issue 9, September 2021
https://link.springer.com/journal/40273/volumes-and-issues/39-9

Articles
Economic Evidence on Potentially Curative Gene Therapy Products: A Systematic Literature Review
Authors (first, second and last of 8)Joseph Khoa Ho, Kennedy Borle, Larry D. Lynd
Content type: Systematic Review
Published: 22 June 2021
Pages: 995 – 1019

PharmacoEconomics
Volume 39, issue 9, September 2021
https://link.springer.com/journal/40273/volumes-and-issues/39-9

A Net Benefit Approach for the Optimal Allocation of a COVID-19 Vaccine
Authors (first, second and last of 5) Erin Kirwin, Ellen Rafferty, Christopher McCabe
Content type: Original Research Article
Open Access
Published: 17 June 2021
Pages: 1059 – 1073

PLoS Biology
August 2021
https://journals.plos.org/plosbiology/issue

Perspectives
Empowering grassroots innovation to accelerate biomedical research
Bastian Greshake Tzovaras, Michael Rera, Edwin H. Wintermute, Katharina Kloppenborg, Juliette Ferry-Danini, Guy Aidelberg, Rachel Aronoff, Ariel Lindner, Dusan Misevic
PLOS Biology: published August 9, 2021 | https://doi.org/10.1371/journal.pbio.3001349

PNAS – Proceedings of the National Academy of Sciences of the United States of America
August 31, 2021; vol. 118 no. 35
https://www.pnas.org/content/118/35

Physical Sciences
Applied Mathematics
Open Access
Optimized delay of the second COVID-19 vaccine dose reduces ICU admissions
Paulo J. S. Silva, Claudia Sagastizábal, Luís Gustavo Nonato, Claudio José Struchiner, and Tiago Pereira
PNAS August 31, 2021 118 (35) e2104640118; https://doi.org/10.1073/pnas.2104640118

Science
Volume 373| Issue 6560| 10 Sep 2021
https://www.science.org/toc/science/current

Policy Forum
Digital exposure tools: Design for privacy, efficacy, and equity
BY Susan Landau
09 Sep 2021: 1202-1204
Apps can cut transmission of SARS-CoV-2-but how do we ensure that they don’t exacerbate public health inequities?

Systematic Reviews
https://systematicreviewsjournal.biomedcentral.com/articles
[Accessed 11 Sep 2021]

Process evaluation of complex interventions in chronic and neglected tropical diseases in low- and middle-income countries—a scoping review protocol
The use of process evaluations is a growing area of interest in research groups working on complex interventions. This methodology tries to understand how the intervention was implemented to inform policy and …
Authors: María Lazo-Porras, Hueiming Liu, J. Jaime Miranda, Graham Moore, Mafalda Burri, François Chappuis, Pablo Perel and David Beran
Citation: Systematic Reviews 2021 10:244
Content type: Protocol
Published on: 7 September 2021

Systematic Reviews
https://systematicreviewsjournal.biomedcentral.com/articles
[Accessed 11 Sep 2021]

A protocol for a systematic literature review of economic evaluation studies of interventions to address antimicrobial resistance
Antimicrobial resistance (AMR) is accelerated by the widespread and often indiscriminate use of antimicrobials in humans, animals, and the environment. In 2015, the World Health Organization recognised AMR as …
Authors: Aparna Ananthakrishnan, Chris Painter and Yot Teerawattananon
Citation: Systematic Reviews 2021 10:242
Content type: Protocol
Published on: 7 September 2021

Vaccine
Volume 39, Issue 35 Pages 4921-5074 (16 August 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/35

Discussion Full text access
Playing vaccine roulette: Why the current strategy of staking everything on Covid-19 vaccines is a high-stakes wager
Elisabeth Paul, Garrett W. Brown, Andreas Kalk, Valéry Ridde
Pages 4921-4924

Vaccine
Volume 39, Issue 35 Pages 4921-5074 (16 August 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/35

Short communication Full text access
COVID-19 vaccine capacity: Challenges and mitigation – The DCVMN perspective
Benoit Hayman, Rajinder Suri, Sai D. Prasad
Pages 4932-4937

Vaccine
Volume 39, Issue 35 Pages 4921-5074 (16 August 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/35

Review article Abstract only
Racial disparities in influenza immunization during pregnancy in the United States: A narrative review of the evidence for disparities and potential interventions
Alice G. Callahan, Victoria H. Coleman-Cowger, Jay Schulkin, Michael L. Power
Pages 4938-4948

Vaccine
Volume 39, Issue 35 Pages 4921-5074 (16 August 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/35

Research article Abstract only
Fear, mistrust, and vaccine hesitancy: Narratives of the dengue vaccine controversy in the Philippines
Vincen Gregory Yu, Gideon Lasco, Clarissa C. David
Pages 4964-4972

Vaccine
Volume 39, Issue 35 Pages 4921-5074 (16 August 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/35

Research article Open access
Does support to Private Health Practitioners increase childhood vaccination coverage? Findings from a comparative study in Afghanistan
Martijn Vink, Nawaraj Upadhaya, Hazrat Amin Amin, Mohammad Gul Liwal, … Maarten Schim van der Loeff
Pages 5007-5014

Vaccine
Volume 39, Issue 35 Pages 4921-5074 (16 August 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/35

Research article Open access
Cost of vaccine delivery strategies in low- and middle-income countries during the COVID-19 pandemic
Christina Banks, Allison Portnoy, Flavia Moi, Laura Boonstoppel, … Stephen C. Resch
Pages 5046-5054

Vaccines
https://www.mdpi.com/journal/vaccines

Open Access Article
Differential Effect of Vaccine Effectiveness and Safety on COVID-19 Vaccine Acceptance across Socioeconomic Groups in an International Sample
by Stefania Kerekes et al
Vaccines 2021, 9(9), 1010; https://doi.org/10.3390/vaccines9091010 (registering DOI) – 11 Sep 2021
Abstract
Controlling the spread of SARS-CoV-2 will require high vaccination coverage, but acceptance of the vaccine could be impacted by perceptions of vaccine safety and effectiveness. The aim of this study was to characterize how vaccine safety and effectiveness impact acceptance of a vaccine, […]

International Entrepreneurship Review
2021, 7(3), 7-21.
https://doi.org/10.15678/IER.2021.0703.01 Open Access
How do intergovernmental organizations embed themselves in global value chains: A case study of Gavi
Melodena Stephens, Immanuel Azaad Moonesar
Abstract
Objective: The article’s objective is to understand how non-MNE actors in the global arena, like intergovernmental organizations (IGOs) embed themselves in the global value chain by using their strong ties to states.
Research Design & Methods: For this study, a qualitative methodology approach investigates an underexplored area of research using a single case study, GAVI, that utilizes thick data.
Findings: The paper contributes to our understanding of IGOs and how they internationalize. New motives are identified, and the concept of soft power has been extended to IGOs.
Implications & Recommendations: IGOs in the humanitarian or developmental sector use soft power strategies to embed themselves in the global value chain. The paper’s implications are for policymakers and practitioners in the third sector, including those who invested interest at state-represented foreign direct investment. Future studies can look at how networks are leveraged, spillover occurs from a personal level to an institutional level, and vice-versa combining diplomacy, bargaining, and legitimacy.
Contribution & Value Added: The study highlights new areas of research like that of soft power. The current internationalization models of SMEs and MNEs may not neatly fit in the context of IGOs (which are born global). We reiterate that existing IB theories need to be applied to other state actors like sovereign wealth funds and non-governmental organizations.

medRxiv
medRxiv is a free online archive and distribution server for complete but unpublished manuscripts (preprints) in the medical, clinical, and related health sciences. Preprints are preliminary reports of work that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information. medRxiv is for the distribution of preprints – complete but unpublished manuscripts – that describe human health research conducted, analyzed, and interpreted according to scientific principles…
https://www.medrxiv.org/content/about-medrxiv
[Accessed 11 Sep 2021]

Selected Content
Relative burdens of the COVID-19, malaria, tuberculosis and HIV/AIDS epidemics in sub-Saharan Africa
David Bell, Kristian Schultz Hansen
medRxiv 2021.03.27.21254483; doi: https://doi.org/10.1101/2021.03.27.21254483

COVID-19 Vaccine Concerns about Safety, Effectiveness and Policies in the United States, Canada, Sweden, and Italy among Unvaccinated Individuals
Rachael Piltch-Loeb, Nigel Harriman, Julia Healey, Marco Bonetti, Veronica Toffolutti, Marcia Testa, Max Su, Elena Savoia
medRxiv 2021.09.09.21263328; doi: https://doi.org/10.1101/2021.09.09.21263328

Determinants and trends of COVID-19 vaccine hesitancy and vaccine uptake in a national cohort of U.S. adults: a longitudinal cohort study
Madhura S Rane, Shivani Kochhar, Emily Poehlein, William You, McKaylee M Robertson, Rebecca Zimba, Drew A. Westmoreland, Matthew L Romo, Sarah G. Kulkarni, Mindy Chang, Amanda Berry, Angela M. Parcesepe, Andrew R. Maroko, Christian Grov, Denis Nash
medRxiv 2021.05.12.21257116; doi: https://doi.org/10.1101/2021.05.12.21257116

Think Tanks et al
 
 
Brookings [to 11 Sep 2021]
http://www.brookings.edu/
Upcoming Event
Accelerating COVID-19 vaccinations in Africa
11:00 AM – 12:00 PM EDT Sep 15

Op-Ed
Africa must produce its own vaccines
Landry Signé
Friday, September 10, 2021
 
 
Center for Global Development [to 11 Sep 2021]
http://www.cgdev.org/page/press-center
Accessed 11 Sep 2021
Before Recommending the RTS,S Malaria Vaccine for Wider Use, WHO Should Address Three Key Considerations
September 8, 2021
Last month, the world woke up to promising news on malaria prevention: administering an existing malaria vaccine (RTS,S) in addition to antimalarial drugs before the rainy season reduced child hospitalizations and deaths by approximately 70 percent in Burkina Faso and Mali. These results arrived ahead of a forthcoming decision from the World Health Organization on whether to recommend RTS,S for broader use. This blog argues that WHO should consider value for money and address three key considerations before making their reccomendation.
Javier Guzman et al.
 
 
Chatham House [to 11 Sep 2021]
https://www.chathamhouse.org/
Accessed 11 Sep 2021
[No new digest content identified]

CSIS
https://www.csis.org/
Accessed 11 Sep 2021
August 27, 2021 News Release
[No new digest content identified]

Kaiser Family Foundation
https://www.kff.org/search/?post_type=press-release
August 27, 2021 News Release
[No new digest content identified]
 
 
Urban Institute [to 11 Sep 2021]
https://www.urban.org/publications
Publications
[No new digest content identified]

Vaccines and Global Health: The Week in Review is a weekly digest  summarizing news, events, announcements, peer-reviewed articles and research in the global vaccine ethics and policy space. Content is aggregated from key governmental, NGO, international organization and industry sources, key peer-reviewed journals, and other media channels. This summary proceeds from the broad base of themes and issues monitored by the Center for Vaccine Ethics & Policy in its work: it is not intended to be exhaustive in its coverage. You are viewing the blog version of our weekly digest, typically comprised of between 30 and 40 posts below all dated with the current issue date

.– Request an Email Summary: Vaccines and Global Health : The Week in Review is published as a single email summary, scheduled for release each Saturday evening before midnight (EDT in the U.S.). If you would like to receive the email version, please send your request to david.r.curry@centerforvaccineethicsandpolicy.org.

– pdf version:  A pdf of the current issue is available here: 

– blog edition: comprised of the approx. 35+ entries posted below.

– Twitter:  Readers can also follow developments on twitter: @vaxethicspolicy.
.
– Links:  We endeavor to test each link as we incorporate it into any post, but recognize that some links may become “stale” as publications and websites reorganize content over time. We apologize in advance for any links that may not be operative. We believe the contextual information in a given post should allow retrieval, but please contact us as above for assistance if necessary.

Support this knowledge-sharing service: Your financial support helps us cover our costs and to address a current shortfall in our annual operating budget. Click here to donate and thank you in advance for your contribution.

.
David R. Curry, MS
Executive Director
Center for Vaccine Ethics and Policy